Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mishaeli

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Harefuah|May 9, 2001
[Integration of erythropoietin in radiotherapy for malignant diseases]M Mishaeli, E Fenig
Cancer Treatment Reviews|March 10, 2001
Pregnancy and radiationE Fenig, M Mishaeli, Y Kalish, et al.
Oncology Reports|June 16, 2000
Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancerB Klein, E Sadikov, M Mishaeli, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1995
The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patientsB Klein, I Levin, B Kfir, et al.
Journal of Chemotherapy (Florence, Italy)|December 29, 2000
A comparison of two dose regimens in pancreatic cancerA Figer, E Sadikov, M Mishaeli, et al.
Oncology Reports|May 21, 2011
Soluble C-erbb-2 (p185) in breast-cancer patients in relation to prognosisB Klein, I Levin, B Kfir, et al.
Oncology Reports|July 31, 1998
Nucleolar organizer regions in conjunctival nevi and melanomataR Koren, L Rath-Wolfson, I Appel, et al.
Neoplasma|December 15, 2006
Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?R Yerushalmi, A Sulkes, M Mishaeli, et al.
Anticancer Research|July 25, 1998
Initial TPS serum level as an indicator of relapse and survival in colorectal cancerM Mishaeli, B Klein, E Sadikov, et al.
ESMO Open|August 13, 2024
Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world dataB Brenner, K Shulman, A Hubert, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Harefuah|May 9, 2001
[Integration of erythropoietin in radiotherapy for malignant diseases]M Mishaeli, E Fenig
Cancer Treatment Reviews|March 10, 2001
Pregnancy and radiationE Fenig, M Mishaeli, Y Kalish, et al.
Oncology Reports|June 16, 2000
Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancerB Klein, E Sadikov, M Mishaeli, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1995
The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patientsB Klein, I Levin, B Kfir, et al.
Journal of Chemotherapy (Florence, Italy)|December 29, 2000
A comparison of two dose regimens in pancreatic cancerA Figer, E Sadikov, M Mishaeli, et al.
Oncology Reports|May 21, 2011
Soluble C-erbb-2 (p185) in breast-cancer patients in relation to prognosisB Klein, I Levin, B Kfir, et al.
Oncology Reports|July 31, 1998
Nucleolar organizer regions in conjunctival nevi and melanomataR Koren, L Rath-Wolfson, I Appel, et al.
Neoplasma|December 15, 2006
Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?R Yerushalmi, A Sulkes, M Mishaeli, et al.
Anticancer Research|July 25, 1998
Initial TPS serum level as an indicator of relapse and survival in colorectal cancerM Mishaeli, B Klein, E Sadikov, et al.
ESMO Open|August 13, 2024
Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world dataB Brenner, K Shulman, A Hubert, et al.
Pageof 1